Actin and its regulators are critical for neuronal function. Infection with herpes simplex virus 1 (HSV-1) remodels neuronal cell actin dynamics, which may relate virus-induced pathological processes in the nervous system. We previously demonstrated that cofilin is an actin regulator that participates in HSV-1-induced actin dynamics in neuronal cells, but how HSV-1 regulates cofilin has remained unclear. In the present study, we demonstrated the HSV-1-induced the inactivation of cofilin and the accumulation of phosphorylated cofilin in the nucleus, which together benefited viral replication. This consistent cofilin inactivation was achieved by the downregulation of slingshot 1 (SSH1). Notably, virus-induced SSH1 downregulation depended on the ubiquitin-proteasome system. Cofilin inactivation is therefore critical for HSV-1 replication during neuronal infection and is maintained by SSH1 downregulation. Moreover, these results provide new insight into the HSV-1-induced neurological pathogenesis and suggest potential new strategies to inhibit HSV-1 replication.
Introduction
Herpes simplex virus 1 (HSV-1), an enveloped DNA virus belonging to the Herpesviridae family, spreads to neurons and causes pathological changes in the central nervous system (Roizman and Whitley, 2007) . Infection with HSV-1 induces neurite damage and neuronal death, and virus-induced neurondegeneration may result from the disruption of the neuronal cytoskeleton (Zambrano et al., 2008) . Although many viruses interact with the cytoskeleton during their life cycle, a striking facet of this interaction is the conversion of cellular actin (Favoreel et al., 2007; Taylor et al., 2011) . For neurons, actin exists on a structural and functional basis (Honkura et al., 2008) . However, the interactions between HSV-1 and actin during neuronal infection are less understood. Previously, we found that HSV-1 induces biphasic dynamics in the actin cytoskeleton of neuronal cells (Xiang et al., 2012) . We also tested the effect of cofilin on HSV-1-induced actin reorganization in neuronal and fibroblast cells Xiang et al., 2012) . Although cofilin has been well known as an actin regulator since its first extraction from porcine brain tissue Nishida et al., 1984) , the detailed role of cofilin in HSV-1 replication remains unclear, and a better understanding of the underlying mechanisms involved in virus-induced cofilin regulation is necessary.
Cofilin is a small protein that binds actin filaments (F-actin), promoting their disassembly (Bamburg et al., 1999) . LIM kinase-1 (LIMK1) promotes cofilin phosphorylation at serine 3 and abolishes the activity of cofilin (Arber et al., 1998; Yang et al., 1998) . The specific phosphatase slingshot (SSH) was later identified to activate cofilin by removing the inhibitory phosphate from serine 3 (Niwa et al., 2002) . Thus, the crosstalk between LIMK1 and SSH plays a pivotal role in the regulation of cofilin activity and actin dynamics. The newly identified phosphatase slingshot-1 (SSH1) was reported to participate in various cellular physiologies, including neuronal function (Zhou et al., 2012) , tumor invasion (Horita et al., 2008) , and neoinitima formation (Torres et al., 2011) , among others. In this paper, we report the first confirmation of the vital role of SSH1 in virus-induced cofilin inactivation. (Biedler et al., 1978) and is sensitive to HSV infection (Orvedahl et al., 2007) . The SK-N-SK cells were infected with HSV-1 at a multiplicity of infection (MOI) of 5 throughout the study. First, we established a real-time PCR-based method to evaluate the replication of HSV-1 and confirmed that disruption of the cytoskeleton could inhibit HSV-1 replication (Fig. 1) . Specifically, the cells were infected with HSV-1 for 4 h to allow sufficient time for viral entry into the nucleus (Xiang et al., 2012) . The cells were then treated with cytochalasin D (Cyto D), latrunculin A, jasplakinolide (Jas), or nocodazole (Noc) for another 20 h. The viral DNA from the cell lysates and the culture supernatants was separately extracted, and real-time PCR was conducted to determine the copy number of the viral gene UL46 as an indication of viral DNA replication.
Disruption of the actin cytoskeleton by Cyto D, Lat A, or Jas greatly reduced the copy numbers of UL46 in the culture supernatants, with inhibitory ratios of 89%, 58%, and 53%, respectively. Disruption of the microtubule cytoskeleton by Noc also reduced the levels of UL46 in the supernatants by 75% (Fig. 1(A) ). The intracellular UL46 levels were suppressed in the presence of Cyto D, Lat A, and Jas by 55%, 26%, and 33%, respectively, whereas only a slight decrease (4%) in UL46 was observed after Noc treatment ( Fig. 1(B) ). Counting the extracellular and intracellular copy numbers together, the relative total UL46 levels were decreased when the cytoskeleton was disrupted either by actin or microtubule inhibitors, demonstrating the inhibitory effects of these chemicals on HSV-1 replication ( Fig. 1(C) ).
Different UL46 copy numbers between the extracellular and intracellular samples may represent the quantities of virions outside or inside the cells. Because the decreases in the extracellular UL46 copy number following Cyto D, Lat A, Jas, or Noc treatment were more obvious compared with the intracellular UL46 DNA copy number, it is possible that viral release may also be affected. Furthermore, the effects of cytoskeleton inhibitors on the replication of HSV-1 were confirmed by titration of the progeny viruses ( Fig. 1(D) ). Together, the above results demonstrate the essential role of the cytoskeleton in HSV-1 replication.
Cofilin is inactivated to benefit HSV-1 replication
We then analyzed the changes in the actin regulator cofilin. During HSV-1 replication, the level of phosphorylated cofilin (p-cofilin) increased, whereas the total cofilin level decreased, leading to an increase in the p-cofilin/cofilin ratio ( Fig. 2(A) ). This increase demonstrated that the level of active cofilin was decreased, indicating that cofilin was deactivated during HSV-1 replication. The changes in F-actin were also examined, and in response to the increased p-cofilin/cofilin ratio, the F-actin intensity tended to decrease (Fig. S1 ). Moreover, p-cofilin tended to localize to the nucleus following infection (Fig. 2(B) ) and did not co-localize with F-actin in the cytoplasm (Fig. 2(C) ). The nuclear localization of p-cofilin was not observed in uninfected cells (Fig. 2(D) ). We further observed the co-localization of p-cofilin and phosphorylated-LIMK (p-LIMK), the active form of LIMK (Edwards et al., 1999; Maekawa et al., 1999) , in the nucleus, suggesting that p-LIMK was recruited to the nucleus to promote cofilin phosphorylation ( Fig. 2(E) ). We overexpressed wild-type (WT) cofilin or two mutant proteins, S3A-cofilin (a non-phosphorylatable form with a mutation of Ser-3 to Ala) and S3E-cofilin (a phosphorylation-mimic with a mutation of Ser-3 to Glu) ( Fig. 2(F) ). Compared with WTcofilin and S3E-cofilin, S3A-cofilin only minimally localized to the nucleus during HSV-1 replication (Fig. S2) . We further assayed the status of HSV-1 DNA replication. Overexpression of S3A-cofilin or WT-cofilin suppressed the copy number of UL46 both in the culture supernatants and inside the cells (Fig. 2(G) ). The effect of S3E-cofilin expression on the copy number of UL46 DNA was less pronounced. The relative total UL46 levels in cells transfected with S3A-cofilin and WT-cofilin were decreased to 42% and 61% of the viral control levels, respectively, whereas the UL46 levels in cells transfected with S3E-cofilin and the pEGFP-N1 control plasmid decreased to 97% and 94% of the viral control levels, respectively. Titration of the progeny virus also demonstrated that overexpression of S3A-cofilin and WT-cofilin significantly reduced HSV-1 replication ( Fig. 2(G) ). These results confirmed that the presence of active cofilin might be an obstacle for HSV-1 replication. Taken together, these results indicate that HSV-1 infection induces cofilin inactivation, promoting the accumulation of p-cofilin in the nucleus, which in turn benefits the viral replication process.
SSH1 downregulation leads to HSV-1-induced cofilin inactivation
We next investigated the pathway regulating cofilin activity. Interestingly, LIMK1 was downregulated after infection ( Fig. 3(A) ). We tested for changes in ROCK1 and PAK1, both of which activate LIMK1 by directly phosphorylating it (Edwards et al., 1999; Maekawa et al., 1999) . Compared with the changes in mockinfected cells, an obvious decreasing trend was observed for ROCK1 following infection. For PAK1, the change was less pronounced than for ROCK1, but a decrease was still observed at late stages of infection (16 h post-infection [p.i.] and 20 h p.i.). These results indicate that the LIMK1 pathway was suppressed and was not the primary cause of the continuous inactivation of cofilin. We analyzed the changes in the SSH1-infected and mock-infected cells and found that SSH1 was downregulated to such an extent following infection that it was difficult to detect by Western blotting. Loss of SSH1 leads to the accumulation of p-cofilin (Niwa et al., 2002) ; thus, SSH1 downregulation is possibly more essential for HSV-1-induced cofilin inactivation than that of alteration of the LIMK1 pathway.
SSH1 is activated by its upstream regulator calcineurin (Wang et al., 2005) ; therefore, we next treated the cells with the calcineurin inhibitor cypermethrin. Cypermethrin increased cofilin activity instead of suppressing it in uninfected cells ( Fig. 3(B) ). We also observed that LIMK1 was downregulated as the SSH1 level decreased after cypermethrin treatment. Thus, the decrease in p-cofilin after cypermethrin treatment might result from the drug-induced LIMK1 downregulation. In the HSV-1-infected cypermethrin-treated group, LIMK1 was further downregulated, and the p-cofilin/cofilin ratio was lower than that in the viral control. However, because of the nearly complete loss of SSH1, the p-cofilin/cofilin ratio was still higher than the cypermethrin-treated uninfected cells. These results further demonstrate that LIMK1 promotes cofilin phosphorylation but that SSH1 downregulation maintains the inactive status of cofilin.
We also knocked down SSH1 using siRNA transfection. In the absence of an HSV-1 infection, transfection with SSH1-targeting siRNA resulted in a distinct loss of SSH1, and LIMK1 was downregulated ( Fig. 3(C) ). Correspondingly, the cofilin activity was suppressed, demonstrating the essential role of SSH1 downregulation on cofilin inactivation. In the HSV-1-infected groups, knockdown of SSH1 led to further downregulation of both SSH1 and LIMK1 compared with the viral control, and cofilin remained inactivated. Downregulation of SSH1 by siRNA decreased the F-actin intensity in uninfected cells, and in HSV-1-infected cells, SSH1 downregulation decreased the F-actin intensity further (Fig. S3A) . Titration of the progeny viruses revealed that SSH1 downregulation by siRNA benefited viral replication (Fig. S3B) .
Together, these results demonstrate that SSH1 downregulation leads to cofilin inactivation, which is critical for HSV-1 replication.
We noted that a change in SSH1 always accompanied a change in LIMK1. In the absence of an HSV-1 infection, the levels of SSH1 and LIMK1 as well as its upstream regulator ROCK1 all increased ( Fig. 3(A) ), and cypermethrin decreased the expression of both SSH1 and LIMK1 (Fig. 3(B) ), and SSH1 knock-down reduced the LIMK1 expression (Fig. 3(C) ). These results indicate that SSH1 and LIMK1 may be closely related and mutually regulated.
We next examined the localization of SSH1, LIMK1, p-LIMK, and p-cofilin. Infection with HSV-1 induced nuclear localization of SSH1 (Fig. 3(D) ), which was not observed for LIMK1 (Fig. S4) . We noticed that SSH1 was almost undetectable by Western blotting following HSV-1 infection but did exhibit a signal under laser-scanning confocal immunofluorescence microscopy (LSM). By using a more lytic buffer to better extract the nuclear protein, we excluded the possibility that the downregulation of SSH1 detected by Western blotting might result from a failure to detect SSH1 localized in the nucleus ( Fig. S5D ; see the comparison between the control and HSV-1-infected groups). These results suggest that there are different sensitivities for Western blotting and LSM. In addition, we found that SSH1 co-localized with both p-LIMK and p-cofilin in the nucleus (Fig. 3(E) and (F) ). Because p-LIMK also co-localized with p-cofilin ( Fig. 2(E) ), we hypothesized that SSH1 and LIMK1 (in its active form p-LIMK) function together to regulate cofilin activity in the nucleus. These results further confirm a previous report suggesting that the interplay between LIMK1 and SSH1 regulates cofilin (Soosairajah et al., 2005). Taken together, the above results demonstrate that SSH1 and LIMK1 are crucial factors for HSV-1-induced cofilin regulation and that SSH1 downregulation consistently leads to virally induced cofilin inactivation.
HSV-1-induced SSH1 downregulation is ubiquitin-proteasome dependent
We found that the transcriptional downregulation of SSH1 following HSV-1 infection was not consistent (Fig. S5A) . Thus, we speculated that a post-transcriptional regulation pathway for SSH1 might be involved. The ubiquitin-proteasome pathway is an essential post-transcriptional mechanism for regulating protein levels (Ciechanover, 1998) . We suppressed this pathway using the inhibitor MG132. Treatment with MG132 inhibited the HSV-1-induced SSH1 downregulation (Fig. 4(A) ). Similar results were observed for LIMK1. In addition, rescue of the total cofilin protein level was observed. In accordance with the changes in SSH1 and LIMK1 levels as well as in cofilin levels after MG132 treatment, the virally induced cofilin inactivation was suppressed. However, although the total cofilin and LIMK1 protein levels increased after MG132 treatment due to the increased SSH1 protein level, the p-cofilin/cofilin ratios were still suppressed compared with the viral control. Similar results were observed using a strong lytic buffer for nuclear protein extraction (Fig. S5D) . This result further demonstrates the significance of SSH1 downregulation in maintaining HSV-1-induced cofilin inactivation.
We next analyzed the status of protein ubiquitination. No obvious global changes in the ubiquitination of cellular proteins were found at 8 h p.i. (Fig. S5E) , indicating that HSV-1 might not affect protein ubiquitination at early stages of the viral life cycle. At 12 h p.i., an increased level of the ubiquitinated protein was found in HSV-1-infected cells. In addition, the MG132 treatment promoted an increase in ubiquitinated proteins, and HSV-1 infection further promoted this increase (Fig. 4(B) ). These results demonstrate that HSV-1 can induce protein ubiquitination during its replication. At 24 h p.i., the amount of ubiquitinated proteins in HSV-1-cells decreased compared with the uninfected cells, and this decrease was also observed in the MG132-treated groups (Fig. 4(C) ), which might be because the virus-induced degradation of cellular proteins had already happened at later stages of infection and thus could not be detected. Nevertheless, by comparing the HSV-1-infected MG132-treated cells with the viral control, we still observed rescue of the ubiquitinated proteins following MG132 treatment. These results suggest an active role for the ubiquitin-proteasome system during HSV-1 replication.
Furthermore, using immunoprecipitation, we identified HSV-1 infection-induced SSH1 ubiquitination (Fig. 4(D) and (E)). Interestingly, we also found that this HSV-1-induced SSH1 ubiquitination was inhibited by MG132 treatment. Together, these results demonstrate that virusinduced SSH1 downregulation is ubiquitin-proteasome dependent.
We assayed the effects of ubiquitin-proteasome inhibition on HSV-1 replication. As presented in Fig. 4(F) , the relative total UL46 levels were suppressed after MG132 treatment, and this effect was not caused by drug cytotoxicity (Fig. S5F) . The progeny viruses were also significantly decreased following MG132 treatment (Fig. 4(F) ). These results suggest an essential role for the ubiquitin-proteasome system in HSV-1 replication. Taken together, the above results demonstrate that the HSV-1-induced downregulation of SSH1 depends on the ubiquitin-proteasome system, which is critical for HSV-1 replication. 
Key role of cofilin in HSV-1 neuronal infection
The regulation of cofilin by viral elements was recently reported (Coiras et al., 2006) , but since that report, little has been elucidated about this issue beyond the HIV infection (JimenezBaranda et al., 2007) . The present study is the first to demonstrate that HSV-1 replication in neuronal cells requires an environment where cofilin is inactivated, which guarantees the potential of cofilin interventions as a strategy to suppress HSV-1 replication. We report that HSV-1 induces cofilin inactivation by downregulating SSH1, rather than by promoting the LIMK1 pathway. To our knowledge, this is also the first report of SSH1 as an essential downstream regulator during viral replication, and a possible interplay between SSH1 and LIMK1 was identified in the context of a viral infection. Thus, as downstream regulators of actin dynamics, SSH1 and LIMK1 also emerge as druggable targets against HSV-1 infection. In addition, the vital role of the ubiquitin-proteasome pathway in cofilin regulation and HSV-1 replication is demonstrated here for the first time, which provides a basis for further elucidating the involvement of the ubiquitinproteasome pathway in the HSV-1 life cycle.
HSV-1 may promote the formation of nuclear actin filaments in neurons (Feierbach et al., 2006) . Nuclear actin is more difficult to detect than cytoplasmic F-actin but is essential for transcription, mRNA export, chromatin remodeling, and nuclear structure and integrity (Favoreel et al., 2007) . The function of nuclear actin during viral infections is currently undetermined. We propose that the accumulation of p-cofilin in the nucleus may hamper the disassembly of nuclear actin, favoring the extensive reproduction of progeny viruses. We screened three viral proteins that may initiate signaling transduction, including US3 (Kato et al., 2011) , ICP0 (Gu and Roizman, 2007) , and UL13 (Kato et al., 2006) . Downregulation of these proteins suppressed HSV-1 replication (Fig. S6A) . However, none of the three proteins completely inhibited cofilin inactivation (Fig. S6B) , indicating that cofilin regulation is not solely induced by any one of these proteins or that other viral elements may be involved. Thus, the viral triggers that initiate cofilin regulation deserve further investigation.
We conclude that HSV-1 induces cofilin inactivation via the ubiquitin-proteasome-dependent downregulation of SSH1 to benefit viral replication in neuronal cells. Cofilin is critical for neuronal functions. It was recently reported that the loss of cofilin in the forebrain causes changes in synaptic actin dynamics and impairments in associative learning (Rust et al., 2010) . Thus, the modulation of cofilin by HSV-1 also provides insight into the mechanisms of HSV-1-induced neurological pathogenesis. Together, our results lay the foundation for further studies of host-pathogen interactions during the HSV-1 neuronal infection to identify novel antiviral targets.
Materials and methods

Antibodies, reagents, and plasmids
Antibodies to p-cofilin (Ser3), LIMK1, p-LIMK1 (Thr508)/LIMK2 (Thr505), PAK1, ROCK1, ubiquitin, and GAPDH were purchased from Cell Signaling Technology. Other antibodies used included anti-cofilin (Cytoskeleton), anti-SSH1 (Abcam), anti-GFP (Abmart), Alexa Fluor 488-or 649-conjugated secondary antibodies (Invitrogen), and horseradish peroxidase-conjugated secondary antibodies (GE Healthcare). TRITC-phalloidin, nocodazole, cypermethrin, and MG-132 were purchased from Sigma. Latrunculin A and jasplakinolide were purchased from Invitrogen. Cytochalasin D was purchased from Gibco, and DAPI was purchased from Biotium.
pEGFP-N1-cofilin had been previously constructed in our laboratory (Xiang et al., 2012) . PCR-mediated mutagenesis was used to mutate Ser-3 into Ala or Glu with primers S3A-cofilin F (5′-GCT TAT GGC CGC CGG TGT GGC TGT C-3′) and S3A-cofilin R (5′-GAC AGC CAC ACC GGC GGC CAT AAG C-3′) or S3E-cofilin F (5′-GCT TAT GGC CGA GGG TGT GGC TGT C-3′) and S3E-cofilin R (5′-GAC AGC CAC ACC CTC GGC CAT AAG C-3′), respectively.
Cells and virus
The human neuroblastoma cell line SK-N-SH (ATCC HTB-11) was propagated in Eagle's minimal essential medium (Invitrogen) supplemented with 10% fetal bovine serum (FBS) (Invitrogen). African green monkey kidney cells (Vero; ATCC CCL81) were cultured in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 10% FBS. The HSV-1 strain F (ATCC VR733) was propagated in Vero cells and stored at À 80 1C. For all of the experiments, the cells were infected with HSV-1 at an MOI of 5.
Western blotting
Cell were harvested and lysed with Strong RIPA Buffer (Beyotime, China). Western blotting was conducted as previously described . For densitometry, the amount of protein in the bands was quantified using ImageJ software and was normalized against the GAPDH levels. The amount of p-cofilin was further normalized against the total cofilin level as an indication of the cofilin activity.
Immunoprecipitation assay
Cell were harvested and lysed with SDS Lysis Buffer (Beyotime, China). The samples were incubated with control IgG and Protein A/G PLUS-Agarose at 4 1C for 30 min. The supernatants were then incubated with an immunoprecipitating antibody at 4 1C for 1 h, and the immune complexes were captured using Protein A/G PLUS-Agarose at 4 1C overnight. The samples were then assayed by Western blotting with specific primary and secondary antibodies.
LSM
The cells were fixed and stained as previously reported (Xiang et al., 2012) . For co-localization observations, the cells were refixed and permeabilized before being stained with the next primary and secondary antibodies. Fluorescence images were recorded using an LSM (LSM 510; Zeiss) under a 63 Â oilimmersion objective (Carl Zeiss).
Transfection
Plasmid transfection was performed with Lipofectamine LTX and Plus reagents (Invitrogen). For the 24-well transfection, 10 μg of plasmid was used, and the cells were grown from 50% to 60% confluence before the transfection. siRNA transfection was conducted using Lipofectamine RNAiMax reagents (Invitrogen). For the 24-well transfection, 2 μg of RNAi duplex was used, and the cells were grown from 30% to 50% confluence before the transfection. At 24 h post-transfection, the cells were used for further studies. The SSH1-siRNA duplex from Sigma consisted of oligonucleotides with the sequences 5′-CAU CUU GGA UGC AAG CAA AdT dT-3′ and 5′-UUU GCU UGC AUC CAA GAU GdT dT-3′. The scrambled siRNA duplex of oligonucleotides 5′-UUC UCC GAA CGU GUC ACG UTT-3′ and 5′-ACG UGA CAC GUU CGG AGA ATT-3′ was used as a negative control.
Viral DNA assay
At 24 h p.i., the culture supernatants were collected, and the cells were trypsinized. The samples were subjected to viral DNA extraction using a UNIQ-10 Viral DNA Kit (Sangon). Real-time PCR was performed to quantify the viral DNA by detecting the viral UL46 gene using the primers UL46F (5′-TCA CCA CGC CCA GTA TAT CA-3′) and UL46R (5′-GCC TTG ATG CTC AAC TCC AT-3′). The assay was performed in a Bio-Rad CFX96 real-time PCR system using the SsoFast EvaGreen Supermix kit (Bio-Rad). The PCR amplification product of UL46 was purified using a Gel Extraction Kit II (U-gene); the amplified DNA was diluted serially and was used as a standard for quantitative analysis. The initial copy number of UL46 DNA was calculated using the following formula: C T ¼ ÀK log X 0 þ b, where C T is the cycle threshold and K, X 0 , and b refer to the slope rate, initial copy number, and constant, respectively. The extracellular and intracellular UL46 copy numbers were determined, and their sums were calculated to measure the relative total UL46 level.
Plaque assay
The virus titers were determined by a plaque assay on Vero cell monolayers in 24-well culture plates (Corning), as previously reported . Briefly, a virus suspension was added to the wells and incubated at 37 1C with 5% CO 2 for 2 h. Next, the virus inoculum was removed, and an overlay medium was added to each well. The cell monolayers were fixed with 10% formalin and stained with 1% crystal violet after another 72 h of incubation. The plaques were then counted, and the virus titration was calculated.
